Methyl prednisolone and lung function after cardiopulmonary bypass.
AUTOR(ES)
Enderby, D H
RESUMO
Thirty-one patients who were undergoing cardiopulmonary bypass for elective aortic valve replacement were studied. The effects on some aspects of lung function of intravenous methyl prednisolone, administered immediately before bypass, were assessed by measuring alveolar-arterial oxygen differences and shunt fractions. No significant differences in pulmonary function were found between the treated and control groups. The use of methyl prednisolone in this context is not justified.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=471176Documentos Relacionados
- Alveolar proteinosis lung lavage using partial cardiopulmonary bypass.
- Transitory cerebral microvascular blockade after cardiopulmonary bypass.
- Ca(2+)-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass.
- Hypoxaemia after aortic valve surgery under cardiopulmonary bypass.
- Incidence and aetiology of a raised hemidiaphragm after cardiopulmonary bypass.